NEW REPORT – The Threat of AMR to Japan’s Super-Aging Society: Implications on Health Care, Public Policy, and Economic Well-Being

New York and Tokyo (February 21, 2021) – Today, the Global Coalition on Aging (GCOA) and the Health and Global Policy Institute (HGPI) announced a report sharing key policy-focused takeaways from their roundtable on antimicrobial resistance (AMR) in super-aging Japan. On October 7, 2020, the roundtable convened experts from across the business, government, academic, aging, and non-profit sectors in a policy discussion that recognized the multifaceted risks of AMR in aging societies around the world, including super-aging Japan. In particular, Japan and other societies have the opportunity to apply lessons from the global COVID-19 response to the AMR challenge. The roundtable was held by GCOA in collaboration with HGPI and sponsored by Pfizer Japan.

Five key takeaways from the roundtable focused on spurring urgent action in the fight against AMR to support of healthy aging and a robust silver economy in super-aging Japan:

  1. AMR is an urgent public health issue, especially for Japan’s super-ageing population. Policy support and decisive actions focused on this vulnerable population are needed.
  2. The dearth of new antimicrobials represents a major market failure that requires new incentives and market-based policy reform.
  3. Empowerment of the ageing population has become increasingly critical in the shadows of COVID-19.
  4. A broad-based, society-wide set of multi-stakeholder interests are needed to address AMR issues.
  5. As the world’s first super-ageing country, Japan is expected to take a leading role on AMR internationally.

Click here to read the report in English. Click here to read the report in Japanese.

Michael W. Hodin, CEO of GCOA, and Dr. Hiroyuki Noda, Councilor at Office for Pandemic Influenza and New Infectious Diseases & Coordination Office of Measures on Emerging Infectious Disease, Cabinet Secretariat, gave opening remarks. Key comments included:

“The Japanese government plays a key role in partnering with businesses to address the growing AMR challenge in our country and around the world. Right now, we need communication and collaboration across sectors. A multi-sectoral approach is the only way to address a challenge of this magnitude,” said Dr. Hajime Inoue, Deputy Director General of the Office for Novel Coronavirus Disease Control, Cabinet Secretariat.

Dr. Norio Ohmagari, Director of the AMR Clinical Reference Center and Director of the Disease Control and Prevention Center of the National of Center for Global Health and Medicine (NCGM) addressed Japan’s unique position as a super-aging society: “The use of injectable antimicrobials for patients over 65 years of age is increasing every year in Japan. As Japan tackles AMR, other aging populations will look to us—the world’s first aging society—for leadership on addressing the AMR challenge in the context of population aging.”

Emphasizing the importance of innovation, Michael W. Hodin said, “Because of Japan’s super-aging status, AMR poses a unique and heightened threat to the country. Despite this urgency, antibiotic innovation has all but dried up. In order to fully support its aging population, Japan must commit to supporting an innovation-friendly environment that incentivizes investment in new antibiotics and fosters a robust pipeline of antibiotics.”

AMR is a principal barrier to healthy aging and threatens lifesaving 20th-century progress in science, medicine, and sanitation in societies around the world, including in super-aging Japan. To read GCOA’s Call to Action to tackle AMR, click here.

 

Global Coalition on Aging

The Global Coalition on Aging aims to reshape how global leaders approach and prepare for the 21st century’s profound shift in population aging. GCOA uniquely brings together global corporations across industry sectors with common strategic interests in aging populations, a comprehensive and systemic understanding of aging, and an optimistic view of its impact. Through research, public policy analysis, advocacy, and strategic communications, GCOA is advancing innovative solutions and working to ensure global aging is a path to health, productivity and economic growth.

 

Health and Global Policy Institute (HGPI)

Health and Global Policy Institute (HGPI) is a Tokyo-based, independent, non-profit, and non-partisan health policy think tank established in 2004. Since its establishment, HGPI has been working to realize citizen-centric health policies by gathering together diverse stakeholders and developing policy recommendations. HGPI is committed to serving as a truly independent organization that can provide society with new ideas from a broad, long-term perspective in order to foster fair and healthy communities. HGPI looks forward to continuing to partner with people from all around the world as we continue our work for the development of effective health policy solutions for Japanese and global issues.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Best Practices for Engaging a Multigenerational Workforce

Employers are grappling with a myriad of workforce-related issues ranging from productivity to attracting and retaining talent, but many may be overlooking some seismic shifts that are reshaping the future of work: longevity, population aging, and the multigenerational workforce.

Brazil Must Fight Antibiotic Resistance

The threat posed by antimicrobial resistance is urgent and spares no country - including Brazil. According to The Lancet, 63 deaths per 100,000 are associated with AMR in Brazil and Paraguay, a rate that exceeds the average for Latin America and the Caribbean. AMR-associated deaths in Brazil are second only to cardiovascular diseases and cancers.

More Than Half of Americans are Unfamiliar with Chronic Kidney Disease, Survey Finds

Chronic kidney disease (CKD) is a major blind spot for many Americans, a new survey suggests. The poll, conducted by the Global Coalition on Aging, asked 1,000 American adults about their understanding and perception of CKD. Though many respondents used the internet for medical information and had a regular doctor and blood work done once or twice a year, 58% of respondents said they were unfamiliar with the illness.

We Missed 100 Million Adult Vaccines – Here’s How We Get Back on Track

Like other pandemics throughout human history, COVID-19 has caused profound changes that are still rippling through our societies, even as people are understandably eager to move on. In fact, these impacts are all the more dangerous when they are largely ignored or effectively invisible. The decline in adult vaccination may be one of the most significant, as a new report finds that ~100 million doses were missed in 2021 and 2022 alone – reversing global progress towards widespread adult immunisation as a new standard of care in a world of more old than young.

New Analysis Shows Lost Ground on Adult Immunisation During the Pandemic with 100 Million Doses Potentially Missed

New data shared today by GSK, in collaboration with the IQVIA Institute for Human Data Science and the Global Coalition on Aging (GCOA), estimate approximately 100 million fewer doses of some adult vaccines (excluding Covid-19 vaccines) were administered in 2021 and 2022 than anticipated, based on the global vaccination adoption trends observed from 2013 to 2020, compounding already low adoption rates pre-pandemic.

Going Beyond Applause: The Potential of Caregiving to Unlock Job Opportunities of the Future

Early in the COVID-19 pandemic, the role of caregivers – staff and family who provide care for older and dependent people to carry out activities such as eating or moving - catapulted to the front of our collective conscience. The daily applause for front-line care workers showed a high level of recognition for their incredible work and provided insight into how our health systems must change as our society ages. We need to continue to recognise caregivers as essential to our ageing society.

High-Level Forum on the Silver Economy 2023

Join us for the High-Level Forum on the Silver Economy 2023. Now in its fourth year, the Silver Economy Forum 2023, December 6 and 7, will explore aging at every stage of life, looking at the growing global Silver Economy through a multigenerational lens. Linking to the goals and aspirations of the UN Decade of Healthy Ageing, SEF 2023 will highlight key themes at the intersection of aging at every age, and the Silver Economy.